Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey.


Journal

Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988

Informations de publication

Date de publication:
07 01 2021
Historique:
received: 15 09 2020
accepted: 11 11 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 13 1 2021
Statut: epublish

Résumé

This is a survey study concerning osteoporosis care during the COVID-19 pandemic in the Netherlands. Respondents reported that osteoporosis care stagnated and lower quality of care was provided. This leads to the conclusion that standardization of osteoporosis care delivery in situations of crisis is needed. During the initial phase of the COVID-19 pandemic, there was no guidance of professional societies or guidelines on the organization of osteoporosis care in case of such a crisis, and treatment relied on local ad hoc strategies. Experiences from the current pandemic need to be taken into account for the near future, and therefore, a national multidisciplinary survey was carried out in the Netherlands. A survey of 17 questions concerning the continuation of bone mineral density measurements by Dual Energy X-ray absorptiometry (DXA), outpatient clinic visits, and prescription of medication was sent to physicians, nurses, nurse practitioners, and physician assistants working in the field of osteoporosis. 77 respondents finished the questionnaire, of whom 39 (50.6%) reported a decline in DXA-scanning and 36 (46.8%) no scanning at all during the pandemic. There was an increase in remote consultations for both new and control patient visits (n = 48, 62.3%; n = 62, 81.7% respectively). Lower quality of care regarding fracture prevention was reported by more than half of the respondents (n = 44, 57.1%). Treatment with intravenous bisphosphonates and denosumab was delayed according to 35 (45.4%) and 6 (6.3%) of the respondents, respectively. During the COVID-19 pandemic, osteoporosis care almost completely arrested, especially because of the discontinuation of DXA-scanning and closing of outpatient clinics. More than half of the respondents reported a substantial lower quality of osteoporosis care during the COVID pandemic. To prevent an increase in fracture rates and a decrease in patient motivation, adherence and satisfaction, standardization of osteoporosis care delivery in situations of crisis is needed.

Identifiants

pubmed: 33415510
doi: 10.1007/s11657-020-00856-8
pii: 10.1007/s11657-020-00856-8
pmc: PMC7790356
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Références

J Orthop. 2020 Jun 06;21:291-296
pubmed: 32549692
Bone. 2017 Dec;105:11-17
pubmed: 28789921
Bone Joint J. 2020 Sep;102-B(9):1219-1228
pubmed: 32634029
J Bone Miner Res. 2020 Jun;35(6):1009-1013
pubmed: 32406536
J Clin Orthop Trauma. 2020 Jul;11(Suppl 4):S431-S441
pubmed: 32774008
Osteoporos Int. 2020 Jul;31(7):1189-1191
pubmed: 32346775
Osteoporos Int. 2021 Jan;32(1):39-46
pubmed: 33057738
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Osteoporos Int. 2020 Apr;31(4):797-798
pubmed: 32065251
Eur J Endocrinol. 2020 Aug;183(2):G57-G65
pubmed: 32396134
Osteoporos Int. 2004 Mar;15(3):175-9
pubmed: 14691617
J Bone Miner Res. 2017 Jun;32(6):1291-1296
pubmed: 28240371
Osteoporos Int. 2020 Sep;31(9):1629-1632
pubmed: 32548787
Lancet. 2020 Mar 14;395(10227):848-850
pubmed: 32151326

Auteurs

Joséphine Jeanne Maria Peeters (JJM)

Department of Internal Medicine, Division of Endocrinology, Center for Bone Quality, Leiden University Medical Center, Leiden, The Netherlands. j.j.m.peeters@lumc.nl.

Peter van den Berg (P)

Fracture Liaison Service, Department of Orthopaedics and Traumasurgery, Reinier de Graaf Gasthuis, Delft, The Netherlands.

Joop P van den Bergh (JP)

Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Internal Medicine, VieCuri Medical Centre, Venray, The Netherlands.
Faculty of Medicine, Hasselt University, Hasselt, Belgium.

Marielle H Emmelot-Vonk (MH)

Department of Geriatrics, University Medical Center Utrecht, Utrecht, The Netherlands.

Gijs de Klerk (G)

Department of Surgery, Admiraal de Ruyter Ziekenhuis Goes, Goes, The Netherlands.

Willem F Lems (WF)

Department of Rheumatology, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.

Elizabeth M Winter (EM)

Department of Internal Medicine, Division of Endocrinology, Center for Bone Quality, Leiden University Medical Center, Leiden, The Netherlands.

M Carola Zillikens (MC)

Bone Center, department of Internal Medicine, section Endocrinology, Erasmus MC Rotterdam, Rotterdam, The Netherlands.

Natasha M Appelman-Dijkstra (NM)

Department of Internal Medicine, Division of Endocrinology, Center for Bone Quality, Leiden University Medical Center, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH